-- 根據《金融時報》週二報道，中國國有的「大基金」正在洽談領投DeepSeek的下一輪融資，該輪融資的估值將達到450億美元。 報告稱，中國積體電路產業投資基金（該基金已投資中芯國際和其他半導體晶片廠商）有意主導此次融資，但最終細節尚未確定。 （市場動態新聞來自與全球市場專業人士的對話。這些資訊被認為來自可靠來源，但可能包含傳聞和推測。準確性無法保證。）
Related Articles
Asia
Rundu Pharmaceutical Gets Nod to Market Losartan Potassium
Zhuhai Rundu Pharmaceutical (SHE:002923) obtained approval from China's National Medical Products Administration for the marketing of losartan potassium, according to a Shenzhen bourse filing on Wednesday.The drug is used for the treatment of primary hypertension and chronic heart failure.The pharmaceutical company's shares rose by less than 2% at the close.
$SHE:002923
International
Final PMI: UK Private Sector Growth Accelerates in April
Britain's private sector output growth increased in April, indicating a moderate rise in manufacturing production and in services sector activity, data from S&P Global showed.The seasonally adjusted S&P Global UK PMI Composite Output Index rose to 52.6 from 50.3 in March, according to final data published Wednesday. The flash estimate stood at 52.Meanwhile, the services PMI came in at 52.7, compared with the previous month's 50.5 and the preliminary reading of 52.
$^FTSE
Australia
Versigent Q1 Net Income Falls, Sales Rise
Versigent (VGNT) reported Q1 net income Tuesday of $81 million, down from $96 million a year earlier.Net sales for the quarter ended March 31 were $2.21 billion, up from $2.02 billion a year earlier.Analysts surveyed by FactSet expected $2.09 billion.The company said it expects 2026 revenue of $9.10 billion to $9.40 billion. Analysts surveyed by FactSet expect $9.25 billion.Shares of the company traded more than 5% higher in recent premarket activity Wednesday.Price: $39.39, Change: $+1.89, Percent Change: +5.04%
$VGNT